The Discounted Cash Flow (DCF) valuation of Arrowhead Pharmaceuticals Inc (ARWR) is (98.82) USD. With the latest stock price at 15.32 USD, the upside of Arrowhead Pharmaceuticals Inc based on DCF is -745.1%.
Based on the latest price of 15.32 USD and our DCF valuation, Arrowhead Pharmaceuticals Inc (ARWR) is a sell. selling ARWR stocks now will result in a potential gain of 745.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 9.9% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (263.64) - (62.76) | (98.82) |
| Upside | -1820.9% - -509.7% | -745.1% |